I need help verifying/checking my answers.

Based on these three statements:

1.

CONSOLIDATED INCOME STATEMENT - USD ($) $ in Millions 12 Months Ended Revenue Cost Gross profit Expense and other (income) Selling, general and administrative Research, development and engineering Intellectual property and custom development income Other (income) and expense Interest expense Total expense and other (income) Income from continuing operations before income taxes Provision for/(benefit from) income taxes Income from continuing operations Income/(loss) from discontinued operations, net of tax Net income Assuming dilution Continuing operations (in dollars per share) Discontinued operations (in dollars per share) Total (in dollars per share) Basic Continuing operations (in dollars per share) Discontinued operations (in dollars per share) Total (in dollars per share) Weighted-average number of common shares outstanding Assuming dilution (in shares) Basic (in shares) Services Revenue Cost Sales Revenue Cost Financing Revenue Cost Dec. 31, 2023 $61,860 27,560 34,300 19,003 6,775 -860 -914 1,607 25,610 8,690 1,176 7,514 -12 $7,502 $8.15 -0.01 8.14 8.25 -0.01 $8.23 922,073,828 911,210,319 $30,378 21,051 30,745 6,127 737 $382 Dec. 31, 2022 $60,530 27,842 32,687 18,609 6,567 -663 5,803 1,216 31,531 1,156 -626 1,783 -143 $1,639 [1] $1.95 -0.16 1.8 1.97 -0.16 $1.82 912,269,062 902,664,190 $30,206 21,062 29,673 6,374 651 $406 Dec. 31, 2021 $57,350 25,865 31,486 18,745 6,488 612 873 1,155 26,649 4,837 124 4712 1,030 $5,743 [2] $5.21 1.14 6.35 5.26 1.15 $6.41 904,641,001 895,990,771 $29,225 19,147 27,346 6,184 780 $534 CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions Current assets Cash and cash equivalents Restricted cash Marketable securities Notes and accounts receivabletrade (net of allowances of $192 in 2023 and $233 in 2022) Short-term financing receivables Held for investment (net of allowances of $129 in 2023 and $145 in 2022) Held for sale Other accounts receivable (net of allowances of $109 in 2023 and $89 in 2022) Inventory Deferred costs Prepaid expenses and other current assets Total current assets Property, plant and equipment Less: Accumulated depreciation Property, plant and equipmentnet Operating right-of-use assetsnet Long-term financing receivables (net of allowances of $27 in 2023 and $28 in 2022) Prepaid pension assets Deferred costs Deferred taxes Goodwill Intangible assetsnet Investments and sundry assets Total assets Current liabilities Taxes Short-term debt Accounts payable Compensation and benefits Deferred income Operating lease liabilities Other accrued expenses and liabilities Total current liabilities Long-term debt Retirement and nonpension postretirement benefit obligations Deferred income Operating lease liabilities Other liabilities Dec. 31, 2023 $13,068 21 373 7,214 6,102 692 640 1,161 998 2,639 32,908 18,122 12,621 5,501 3,220 5,766 7,506 842 6,656 60,178 11,036 1,626 135,241 2,270 6,426 4,132 3,501 13,451 820 3,521 34,122 50,121 10,808 3,533 2,568 11,475 Dec. 31, 2022 $7,886 103 852 6,541 6,851 939 817 1,552 967 2,611 29,118 18,695 13,361 5,334 2,878 5,806 8,236 866 6,256 55,949 11,184 1,617 127,243 2,196 4,760 4,051 3,481 12,032 874 4,111 31,505 46,189 9,596 3,499 2,190 12,243 Total liabilities 112,628 105,222 Commitments and Contingencies IBM stockholders' equity Common stock 59,643 58,343 Retained earnings 151,276 149,825 Treasury stock, at cost (shares: 2023-1,351,897,514; 2022-1,351,024,943) -169,624 -169,484 Accumulated other comprehensive income/(loss) -18,761 -16,740 Total IBM stockholders' equity 22,533 21,944 Noncontrolling interests 80 77 Total equity 22,613 22,021 Total liabilities and equity $135,241 $127,243CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions 12 Months Ended Dec. 31, 2023 Dec. 31, 2022 Dec. 31, 2021 Cash flows from operating activities Net income $7,502 $1,639 [1] $5,743 [2] Adjustments to reconcile net income to cash provided by operating activities Pension settlement charge 0 5,894 0 Depreciation [3] 2,109 2,407 3,888 Amortization of capitalized software and acquired intangible assets 2,287 2,395 2,529 Stock-based compensation 1,133 987 982 Deferred taxes -1,114 -2,726 -2,001 Net (gain)/loss on asset sales and other [4] -170 -363 -136 Change in operating assets and liabilities, net of acquisitions/divestitures Receivables (including financing receivables) 725 -539 1,372 Retirement related -462 331 1,038 Inventory 390 71 138 Other assets/other liabilities [4] 1,466 126 -842 Accounts payable 65 213 85 Net cash provided by operating activities 13,931 10,435 12,796 Cash flows from investing activities Payments for property, plant and equipment -1,245 -1,346 -2,062 Proceeds from disposition of property, plant and equipment 321 111 387 Investment in software -565 -626 -706 Purchases of marketable securities and other investments -11,143 -5,930 -3,561 Proceeds from disposition of marketable securities and other investments 10,647 4,665 3,147 Acquisition of businesses, net of cash acquired -5,082 -2,348 -3,293 Divestiture of businesses, net of cash transferred -4 1,272 114 Net cash provided by/(used in) investing activities -7,070 -4,202 -5,975 Cash flows from financing activities Proceeds from new debt 9,586 7,804 522 Payments to settle debt -5,082 -6,800 -8,597 Short-term borrowings/(repayments) less than 90 daysnet -7 217 -40 Common stock repurchases for tax withholdings -402 -407 -319 Financingother 176 176 70 Distribution from Kyndryl 0 0 879 [5] Cash dividends paid -6,040 -5,948 -5,869 Net cash provided by/(used in) financing activities -1,769 -4,958 -13,354 Effect of exchange rate changes on cash, cash equivalents and restricted cash 9 -244 -185 Net change in cash, cash equivalents and restricted cash 5,101 1,032 -6,718 Cash, cash equivalents and restricted cash at January 1 7,988 6,957 13,675 Cash, cash equivalents and restricted cash at December 31 13,089 7,988 6,957 Cash, cash equivalents and restricted cash at December 31 13,089 Supplemental data Income taxes paidnet of refunds received 1,564 Interest paid on debt 7,988 6,957 1,865 2,103 $1,668 $1,401 $1,512 Amounts in Millions Year 0 2 3 4 5 Revenues (3% of the total revenue) $1,855.80 2134.17 2347.587 2464.966 2588.215 Growth in Rev 15% 10% 5% 5% Oper Income = total revenue * operating margin 440.79 506.9085 557.5994 585.4793 614.7533 Margin = (EBIT + Depreciation)/Total revenue 23.75% Depreciation = PPE/5 362.44 398.684 418.6182 422.8044 427.0324 Tax Rate 26.00% Capital Expenditure 1812.2 1993.42 2093.091 2114.022 2135.162 2156.514 Growth in Exp 10% 5% 1% 1% 1% Chg Cap Exp 1812.2 181.22 99.671 20.93091 21. 14022 21.35162 NWC/Sales 0.07 NWC 127.29 146.3835 161.0219 169.0729 177.5266 OO Chg NWC 127.29 19.0935 14.63835 8.051093 8.453647 Recover NWC -177.527 FCF (millions) -1812.2 111.909 360.0056 485.895 513.9925 358.614 Cost of Capital 12% NPV -$549.298 IRR 0% Part 4 NPV IRR a 2% 4% b 10% 15% C 0% 10%